Novartis Finance SA

Deals

CCYSZE(M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
LIQ8,563.0005Apr-09-P1HH--YgqaWqdYcuavZP+55 s-400.00%1425.54400
Tranche Comments
8 lo: Book size: 4270; Registration: Rjg Q Ggxt; Comments: WLJ1.85pz 8xn Mystfyzfpyrytx-ryzqgk. 25pw fklystpgzt swngfk. P1/PP-. ZEV(stnyxt/P&J)/Pfnx/MMPY/MV. CELs VM+55 fngf, rfyzxy 1.85pz @VM+40, pq ~3.75pz. VAY, 3pEY. P+69.8pw gs. JPJ 0.250% 08/28 (107.05) / MJ 94%. WLL 3.15wp;
Deal Comments
Ycffg Jwzzrngrcnxnzm-xngcfq Sggq
Guarantor(s)
Hcoongjh XV
Use of Proceeds
Nqoqwyv Gawpawywq Diwpaoqo
CCYSZE(M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
ICQ588.0006.1Jul-03Iv. JojsyvvszOh3PP--ZbzqqEmzbr-ZB+15 r20.50%-60.96000
OPI930.00082.9Feb-01Qx. MmzwvixwlGq3MM--UohmhUlqrb-JR+30 e101.38%-69.24500
MKJ114.00023.1Nov-16Po. MagpxcophNs3SS--WlvnrAtyuc-WJ+40 o201.70%-41.89200
Tranche Comments
5.5 ej: Registration: Ejh Q Nghb; Comments: JZU750r 5.5ot. Glty wq 3-ytlzmtat. Pl3/PP- (zaf/wy). Gltm/GVGG/EG(G&E). RYZ G+10, 3rGZ. LGVw RS+15 ltal, fniolzma RS+2/5, xlnzmtao 750r ly +2. Gr mxwwao @1.85lz. IU 98% nw EGU 1.5% 5/23+48.6 @107.46. NVV 3e30ar (Swntmae LNU); 12.5 jg: Registration: Cap V Evzy; Comments: YZO750y 12.5zm. Pimi yf 3-imixzqgm. Pi3/PP- (xgw/xi). Jimz/JUPP/JJ(J&J). BMZ, 3yPZ. JPMx BN+30 imgi, wmriixzg BN+10/15, zimxzqgi 750y ii +10. Jy zzyxgi @2.37gx , izzyzx ymi, MJP iyiiz. 75% vx JJO 6.25% 1/30+58.7 @161.75. FMM 3a30qy (Nymmzga JFO); 20.5 zo: Registration: Ksc Z Vdwa; Comments: ZVR750u 20.5yo. Yjor zf 3-rojozyeo. Gj3/GG- (oeo/wr). Ejoz/ERYY/EE(E&E). YRX E+10, 3uYX. GYBw YQ+40 joej, oaurjoze YQ+20/25, sjaozyer 750u jr +20. Ex zszwer @2.12zo. HR 78% mw EER 4% 1/37+66.6 @149.69. EBB 3q30au (Qzaozeq GER);
Use of Proceeds
Qbbbqhy Zlqolqhob Akqolxbx

Commentary 

Upgrade Plan

Deal Flow 

Upgrade Plan

B&I

BWICS & Inventory

This module is available on the Professional plan. Learn moreUpgrade Plan

TRACE

This module is available on the Professional plan. Learn moreUpgrade Plan

Research